OPKO Health (OPK) Cash Flow Statement

Click line-items for a historical chart and %

Net loss
Depreciation and amortization	72.61M
Accretion of debt discount related to notes payable
Equity-based compensation - employees and non-employees	34.94M
Loss from investments in investees
Provision for bad debt
Provision for (reversal of) inventory reserves
Accounts receivable	-28.97M
Inventory	-2.73M
Prepaid expenses and other current assets	-24.31M
Other assets	-402K
Accounts payable	-16.14M
Accrued expenses	36.02M
Net cash used in operating activities	1.74M
Acquisition of businesses, net of cash	15.88M
Purchase of marketable securities	-15.63M
Maturities of short-term marketable securities
Capital expenditures	-17.02M
Net cash used in investing activities	-14.22M
Issuance of common stock, including related parties, net
Purchase of common stock held in treasury
Redemption of Series A Preferred Stock
Repayment of line of credit with related party
Borrowings under lines of credit
Repayments under lines of credit
Proceeds from the exercise of stock options and warrants	6.11M
Net cash provided by (used in) financing activities	-36.97M
Effect of exchange rate changes on cash and cash equivalents	504K
Net increase (decrease) in cash and cash equivalents	-48.95M
Cash and cash equivalents at beginning of period	193.6M
Cash and cash equivalents at end of period	144.65M
Interest paid	2.52M
Income taxes paid, net	8.05M
Issuance of capital stock to acquire Exakta-OPKO	4.86M

Entities mentioned with OPK

View All Entities